COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Treating Co-Occurring Substance Use and Mental Disorders Among Jail Inmates

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02214667
Recruitment Status : Terminated (Inability to recruit enough participants)
First Posted : August 12, 2014
Last Update Posted : March 17, 2020
University of North Carolina, Chapel Hill
Boston University
Information provided by (Responsible Party):
RTI International

Brief Summary:
Treatment adaptation and implementation study for adult jail inmates with co-occurring substance use disorders.

Condition or disease Intervention/treatment Phase
Co-occurring Mental and Substance Use Disorders Crime Criminogenic Thinking Implementation Adaptation Behavioral: Dual-diagnosis motivational interviewing (DDMI) Behavioral: Integrated group therapy (IGT) Behavioral: Jail and community-based behavioral health services Not Applicable

Detailed Description:
We will adapt dual-diagnosis motivational interviewing and integrated group therapy for jail inmates with co-occurring substance use and mental health disorders and to evaluate the feasibility of implementing the adapted interventions and associated research and communication protocols.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 8 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Treating Co-Occurring Substance Use and Mental Disorders Among Jail Inmates
Actual Study Start Date : May 21, 2015
Actual Primary Completion Date : June 30, 2019
Actual Study Completion Date : June 30, 2019

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: DDMI-IGT
Subjects randomized to the experimental condition will receive adapted versions of dual-diagnosis motivational interviewing ([DDMI] one session before release from jail) and integrated group therapy ([IGT] 12 community-based sessions over a 2-month period).
Behavioral: Dual-diagnosis motivational interviewing (DDMI)
DDMI is an evidence-based adaptation to motivational interviewing. DDMI incorporates an integrated framework and accommodates cognitive impairments and disordered thinking associated with co-occurring substance use and mental disorders.

Behavioral: Integrated group therapy (IGT)
IGT is an evidence-based practice for treating co-occurring disorders. IGT focuses on relapse prevention by reducing substance use and stabilizing psychiatric symptoms.

Active Comparator: Usual care
Subjects randomized to the usual care condition will receive jail and community-based behavioral health services.
Behavioral: Jail and community-based behavioral health services
Existing behavioral health service programs

Primary Outcome Measures :
  1. Acceptability [ Time Frame: Study months 21 through 34 ]
    Client Satisfaction Questionnaire-8, Narrative Evaluation of Intervention Interview

Secondary Outcome Measures :
  1. Feasibility of Adapted Interventions [ Time Frame: Study months 21 through 34 ]
    How successfully can the adapted interventions be implemented (Focus Group interviews)

  2. Fidelity [ Time Frame: Study months 21 through 34 ]
    DDMI and IGT Adherence Forms

  3. Substance use [ Time Frame: Study months 20 through 30 ]
    Addiction Severity Index

  4. Psychiatric symptoms [ Time Frame: Study months 20 through 30 ]
    Brief Psychiatric Rating Scale

  5. Health status [ Time Frame: Study months 20 through 30 ]

  6. Service use [ Time Frame: Study months 20 through 30 ]
    Epidemiological Catchment Area Interview

  7. Externalizing behaviors [ Time Frame: Study months 20 through 30 ]
    Triarchic Psychopathy Measure

  8. Quality of life measure [ Time Frame: Study months 20 through 30 ]
    Heinrichs-Carpenter Quality of Life Scale, Plus

  9. Arrest [ Time Frame: Study months 20 through 30 ]
    Self-report and official jail records

  10. Treatment preferences [ Time Frame: Study months 20 through 30 ]
    Visual analog ranking of 8 different aspects of treatment

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • (1) drug or alcohol abuse or dependence and SMI (major depressive disorder; depressive disorder not otherwise specified [NOS]; bipolar disorder I, II, or NOS; schizophrenia spectrum disorder; schizoaffective disorder; schizophreniform disorder; brief psychotic disorder; delusional disorder; or psychotic disorder NOS);
  • (2) resident of Wake County and detained in The Jail;
  • (3) >18 years of age; (4) able to speak/read English; and (5) able to provide informed consent.

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02214667

Layout table for location information
United States, North Carolina
RTI International
Research Triangle Park, North Carolina, United States, 27709
Sponsors and Collaborators
RTI International
University of North Carolina, Chapel Hill
Boston University
Layout table for investigator information
Principal Investigator: Richard A Van Dorn, Ph.D. RTI International

Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: RTI International Identifier: NCT02214667    
Other Study ID Numbers: R34DA036791 ( U.S. NIH Grant/Contract )
First Posted: August 12, 2014    Key Record Dates
Last Update Posted: March 17, 2020
Last Verified: March 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Keywords provided by RTI International:
co-occurring disorders
Additional relevant MeSH terms:
Layout table for MeSH terms
Substance-Related Disorders
Mental Disorders
Psychotic Disorders
Pathologic Processes
Schizophrenia Spectrum and Other Psychotic Disorders
Chemically-Induced Disorders